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The study of type III RNases constitutes an important area in molecular biology. It is known that the pac1+
gene encodes a particular RNase III that shares low amino acid similarity with other genes despite having
a double-stranded ribonuclease activity. Bioinformatics methods based on sequence alignment may fail when
there is a low amino acidic identity percentage between a query sequence and others with similar functions
(remote homologues) or a similar sequence is not recorded in the database. Quantitative structure-activity
relationships (QSAR) applied to protein sequences may allow an alignment-independent prediction of protein
function. These sequences of QSAR-like methods often use 1D sequence numerical parameters as the input
to seek sequence-function relationships. However, previous 2D representation of sequences may uncover
useful higher-order information. In the work described here we calculated for the first time the spectral
moments of a Markov matrix (MMM) associated with a 2D-HP-map of a protein sequence. We used MMMs
values to characterize numerically 81 sequences of type III RNases and 133 proteins of a control group. We
subsequently developed one MMM-QSAR and one classic hidden Markov model (HMM) based on the
same data. The MMM-QSAR showed a discrimination power of RNAses from other proteins of 97.35%
without using alignment, which is a result as good as for the known HMM techniques. We also report for
the first time the isolation of a new Pac1 protein (DQ647826) from Schizosaccharomyces pombe strain
428-4-1. The MMM-QSAR model predicts the new RNase III with the same accuracy as other classical
alignment methods. Experimental assay of this protein confirms the predicted activity. The present results
suggest that MMM-QSAR models may be used for protein function annotation avoiding sequence alignment
with the same accuracy of classic HMM models.
1. INTRODUCTION
RNase III is a double-strand-specific ribonuclease (dsR-
Nase) that usually makes staggered cuts in both strands of a
double helical RNA, although in some cases it cleaves once
in a single-stranded bulge in the helix.1,2 The primary
biological function of this system is the specific processing
of rRNA and mRNA precursors,3-5 but it has also been
implicated in other diverse phenomena such as mRNA
turnover,6 conjugative DNA transfer,7 antisense RNA-
mediated regulation, and others.8,9 For instance, Dicer and
Drospha are type III RNases responsible for the generation
of short interfering RNAs (siRNAs) from long double-
stranded RNAs during RNA interference (RNAi). Also, the
cellular processing of shRNAs shares common features with
the biogenesis of naturally occurring miRNA such as
cleavage by nuclear type III RNase Drosha, export from the
nucleus, processing by a cytoplasmic type III RNase Dicer,
and incorporation into the RNA-induced silencing complex
(RISC). Each step has a crucial influence on the efficiency
of RNAi.10-13 It involves both RNase proteins in several
important biological processes as for instance the function
of Dicer on the vascular system regulating embryonic
angiogenesis probably by processing miRNAs, which regu-
late the expression levels of some critical angiogenic
regulators in the cell.14 Recently, RNAi has moved from a
purely experimental technique to the stage of potential
clinical applications such as a possible use for the treatment
of spinocerebellar ataxia or amyotrophic lateral sclerosis.15
Many other dsRNases have been characterized from a variety
of prokaryotic and eukaryotic sources, and RNase III from
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Escherichia coli is an archetype of this class of enzymes.6,16,17
The RNase III family consists of a growing number of
enzymes that includes at least 33 bacterial and 22 eukaryotic
enzymes.18 There have been numerous reports of dsRNase
activities in eukaryotic cells, some of which exhibited
properties consistent with a role in pre-rRNA processing.19-21
One of the best candidates for eukaryotic RNase III
homologues is the Pac1 RNase from Schizosaccharomyces
pombe.22-24 The Pac1 product is derived from Schizosac-
charomyces pombe pac1+ gene expression, which is also
involved in the regulation of sexual development,25 possibly
through a mechanism that involves the processing of certain
small nucleolar RNAs (snRNAs).26 Pac1 works in eukaryotes
as dsRNase and shares a functional similarity to RNase III
from E. coli. This fact was proved either by measuring the
ability of Pac1 to degrade double-stranded RNA in vitro or
by expressing pac1+ in E. coli, where it produced an activity
that converted dsRNA into acid-soluble products.23 Despite
these observations the Pac1 gene product shows low homol-
ogy with other RNAse III enzymes, particularly with those
ones belonging to bacteria. The homology between the
different RNase III enzymes varies in the range 20-84%
depending on their evolutionary distance, suggesting a low
level of primary structure conservation.27 It has been reported
that antibodies prepared against Pacl RNase have failed to
react with RNase III.23 The Pac1 gene product from
Schizosaccharomyces pombe belongs to subclass II of the
RNase III family, which is characterized by the presence of
an N-terminal extension and includes fungal RNase III.27,28
This contains 363 amino acids (aa), and only its C-terminal
230 residues share 25% amino acid identity with the
Escherichia coli ribonuclease III.23
Methods based on sequence alignment have revealed a
low amino acidic identity (20-40%) for the pac1+ gene
product with other typical RNases III, either isolated from
bacteria or even from species that are genetically close.27,29
However, experimental observations show the Pac1 protein
to be a dsRNAse enzyme. This relatively low degree of
conservation probably reflects the species-specificity of
RNase III, which prevents genetic complementation between
members of the RNase III family.30
All of the facts discussed above hinder the prediction of
the Pac1 gene product as an RNase III-like enzyme using
computational methods based on sequence alignment. In fact,
bioinformatics methods based on sequence alignment may
fail in general for cases of low sequence homology between
the query and the template sequences deposited in the data
base. The lack of function annotation (defined biological
function) for the sequences deposited in databases and used
as templates for function prediction constitutes another
weakness of alignment approaches.31,32 Recently, a group of
researchers published in PROTEOMICS (2006) a review33
on the growing importance of machine learning methods for
predicting a protein functional class independently of se-
quence similarity. In this review the authors make reference
to various papers on the topic, including their own work.34-45
These methods often use as the input 1D sequence numerical
parameters specifically defined to seek sequence-function
relationships. For instance, the so-called pseudoamino acid
composition approach46,47 based on 1D sequence coupling
numbers has been widely used to predict subcellular local-
ization, enzyme family class, and structural class as well as
other attributes of proteins based on their sequence
similarity.45,48-74 Alternatively, some authors generalized
molecular indices that are classically used for small mol-
ecules75,76 to describe protein sequences, such as the gener-
alization of Broto-Moreau indices by Caballero and Ferna´n-
dez et al.77 On the other hand, many authors have introduced
2D or higher dimension representations of sequences prior
to the calculation of numerical parameters. This constitutes
an important step in order to uncover useful higher-order
information not encoded by 1D sequence parameters.78-98
In addition, 2D graphs have been used for proteins and DNA
sequences by other researchers. For example, Zupan and
Randic´ used spectral-like and zigzag representations. These
authors suggested an algorithm for encoding long strings of
building blocks (like 4 DNA bases, 20 natural amino acids,
or all 64 possible base triplets) using “zigzag” or “spectrum-
like” representations.99 Hydrophobic cluster analysis (HCA)
constitutes another well-known technique for the 2D repre-
sentation of protein sequences.100 Randic´ et al. ultimately
approached protein representations by using 2D schemes
based on nucleotide triplet codons or virtual genetic code.101
Finally, we introduced hydrophobicity-polarity (HP) 2D
Cartesian or latticelike representations for proteins related
to plant metabolism.93
In this work, we propose to use the spectral moments of
a Markov matrix (MMM) associated to a 2D-HP-graph to
numerically characterize protein sequences and seek a QSAR
model to predict type III RNAses without alignment. First,
we derived hydrophobicity-polarity (HP) 2D Cartesian or
latticelike representations (also called maps or graphs) for
RNase III and control group protein sequences.93 We then
calculated the MMM values of order k (symbolized as SRðk)
to characterize the protein sequence. Spectral moments for
many kinds of graphs have been used before for quantitative
structure-activity relationships (QSAR) studies on pro-
teins.102-112 We subsequently developed a classifier to
connect protein sequence information (represented by the
SRðk values) with the classification of sequences as RNAse
III or not. In general, different kinds of classifiers have been
used to derive protein sequence QSAR models.113,114 We
selected a linear discriminant analysis (LDA), which is a
simple but powerful technique.115-121 The use of this MMM-
QSAR model enabled us to predict a novel recombinant Pac1
(rPac1) protein as an RNase III-like enzyme from a new
isolate of Schizosaccharomyces pombe. Prediction was also
supported by profile Hidden markov model (HMM) analysis
and submission to BLASTp and InterPro122 servers and
demonstrated by experimental evidence.
2. MATERIALS AND METHODS
2.1. Computational Methods. A Markov model (MM),
also called MARCH-INSIDE, was used to codify information
about 81 RNase III protein sequences belonging to prokary-
ote and eukaryote species downloaded from the GenBank
database. Briefly, our methodology considers as states of the
Markov chain (MC) any atom, nucleotide, or amino acid (aa)
depending on the kind of molecule to be described.123,124
Therefore, MM deals with the calculation of the probabilities
(kpij) with which the charge distribution of aa moves from
any aa in the vicinity i at time t0 to another aa j along the
protein backbone in discrete time periods until a stationary
state is achieved.125,126
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Each RNase III sequence was labeled by its accession
number; see Table 1 in the Supporting Information. The
control group consists of 133 proteins, which were selected
from 2184 high-resolution proteins in a structurally nonre-
dundant subset of the Protein Data Bank (PDB); most of
the data were published by other authors to distinguish
enzymes and nonenzymes without alignment127 (see Table
2 in the Supporting Information). Many researchers have
demonstrated the possibility of predicting protein function
from sequences,128 and we used 2D-HP graphs to encode
information about RNase III amino acid sequences.93 We
then calculated for the first time the HPðk values for these
graphs. As can be seen from the discussion above, we
selected HPðk based on the utility of other nonstochastic
spectral moments103-112 as well as other MMMs and other
stochastic parameters.102,129-131
It is important to point out that this 2D graphical
representation for proteins is similar to those previously
reported for DNA,92,96,97 but the 20 different amino acids
are regrouped into HP classes instead of using 4 types of
bases. These four groups characterize the HP physicochem-
ical nature of the amino acids as polar, nonpolar, acidic, or
basic.132 The 2D-HP graph for the deduced amino acid
sequence of rPac1 protein, obtained from Schizosaccharo-
myces pombe strain 428-4-1 (uploaded by our group with
accession number DQ647826), is shown in Figure 1. It is
worth noting that 363 amino acids are rearranged in a 2D
space compacting protein representation. Each amino acid
in the sequence is placed in a Cartesian 2D space starting
with the first monomer at the (0, 0) coordinates. The
coordinates of the successive amino acids are calculated as
follows: a) increase by +1 the abscissa axis coordinate for
an acid amino acid (rightwards-step), or b) decrease by -1
the abscissa axis coordinate for a basic amino acid (leftwards-
step), or c) increase by +1 the ordinate axis coordinate for
a polar amino acid (upward-step), or d) decrease by -1 the
ordinate axis coordinate for a nonpolar amino acid (downward-
step).
2.2. 2D-HP Graph MMMs Used as Sequence Numer-
ical Descriptors. After the representation of the sequences
we assigned to each graph a stochastic matrix 1ƒ. Note that
the number of nodes (n) in the graph is equal to the number
of rows and columns in 1ƒ but may be equal to or even
smaller than the number of amino acids or DNA bases in
the sequence. The elements of 1ƒ are the probabilities 1pij
of reaching a node ni with charge Qi moving through a walk
of length k ) 1 from another node nj with charge Qj133
where Rij equals 1 if the nodes ni and nj are adjacent in the
graph and equal to 0 otherwise. Qj is equal to the sum of
the electrostatic charges of all amino acids placed at this
node. It then becomes straightforward to carry out the
calculation of the spectral moments of 1ƒ in order to
numerically characterize the protein sequence
where Tr is called the trace and indicates that we sum all
the values in the main diagonal of the matrices kƒ ) (1ƒ)k,
Table 1. Classification Results Derived from the Model for
Training and Validation Series
MMM training MMM validation
total% 97.35 RNases control RNases control 100 total%
RNases 93.44 57 4 20 0 100 RNases
control 100 0 90 0 43 100 control
MMM all sequences HMM classic
total% 98.1 RNases control RNases control 97.50 total%
RNases 95.1 77 4 80 1 98.75 RNases
control 100 0 133 5 128 96.24 control
Table 2. Enzymatic Assay of Double-Stranded RNase Recombinant
Pac1 DQ647826 Extracted from Schizosaccharomyces pombe Strain
428-4-1
conc. rPac 1 1nM 10 nM 100 nM
EUVa 6.2  105 7.4  105 7.2  105
6.0  105 6.8  105 7.3  105
6.6  105 6.9  105 7.9  105
mean 6.4  105 7.0  105 7.5  105
a Enzymatic unit value for rPac 1 (U/mg).
Figure 1. 2D Cartesian representation for the amino acid sequence
of the rPac1 protein Schizosaccharomyces pombe strain 428-4-1,
GenBank accession number DQ647826. Note that a node may













kpij ) Tr[(1ƒ)k] (2)
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which are the natural powers of 1ƒ. The present class of
MMMs encodes in a stochastic manner the distribution of
the amino acid properties (charge) through all of the nodes
placed at different distances in the 2D-HP lattice. Expansion
of expression 2 for k ) 0 gives the order zero MMM0 (HPð0);
for k ) 1 the short-range MMM1 (HPð1), for k ) 2 the
middle-range MMM2 (HPð2), and for k ) 3 the long-range
MMMs. This extension is illustrated for the linear graph n1-
n2-n3, which is characteristic of the sequence (Asp-Glu-Asp-
Lys); please note that the central node contains both Glu
and Asp:93
All calculations of HPðk values for protein sequences of
both groups were carried out with our in-house software
MARCH-INSIDE, version 2.0, including sequence repre-
sentation.134 We proceeded to upload a row data table with
eleven HPðk values for each sequence (k ) 0, 1, 2,...10) and
grouping variable RNaseIII-score ) 1 (for RNAses) and -1
(for control group sequences) to statistical analysis soft-
ware.135 The overall methodology is represented schemati-
cally in order to improve the understanding of our approach
(see Figure 2).
2.3. Statistical Analysis. K-Means Cluster Analysis. The
negative group was selected from 2184 proteins with diverse
functions (enzymes and nonenzymes) recorded in the PDB,
as mentioned before. Our negative subset was designed
according to K-means cluster analysis (k-MCA).136 The
method consists of carrying out a partition of the starting
group made up by a non-RNase III series of proteins into
several statistically representative clusters of sequences. Thus,
one may select the members to conform to the negative
subset from all of these clusters. This procedure ensures that
the main protein classes (as determined by the clusters
derived from k-MCA) will be represented in the model
control group, thus allowing the representation of the entire
‘experimental universe’. The spectral moment series was
explored as clustering variables in order to carry out k-MCA.
The procedure described above is represented graphically
in Figure 3, where a cluster analysis was carried out to select
a representative sample for the control group.
2.4. Linear Discriminant Analysis. LDA forward step-
wise analysis was carried out for variable selection to build
up the model.115-121 All of the variables included in the model
were standardized in order to bring them onto the same scale.
Subsequently, a standardized linear discriminant equation that
allows comparison of their coefficients was obtained.137 The
square of Mahalanobis’s distance (D2) and Wilk’s (ì) statistic
(ì ) 0 perfect discrimination, being 0 < ì < 1) were
examined in order to assess the discriminatory power of the
model. Pac1 protein was submitted to BLASTp to show
graphically the similarity of the sequence compared to other
RNases III. Each sequence presented in this study was also
submitted to the InterPro server122 in order to compare our
methodology with other classical sources of predictive
functional annotation. InterPro consists of a database of
protein families, domains, and functional sites in which
identifiable features found in known proteins can be applied
to unknown protein sequences.
3. EXPERIMENTAL SECTION
3.1. Strains and Culture Media. The Schizosaccharo-
myces pombe strain 428-4-1 was routinely grown in yeast
extract (YEB) medium at 30 °C during 12 h. Bacterial strain
Escherichia coli DH5R was grown in luria broth (LB).
Transformed bacteria were recovered in the same LB
HPð0 ) Tr[(1ƒ)0] ) Tr([1 0 00 1 00 0 1 ]) ) 3 (2a)
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Figure 2. Schematic representation of the steps given in this work.
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medium but supplemented with carbenicillin at 100 íg/mL.
Media were also supplemented with bacteriological agar
when required.
3.2. Total DNA Extraction. A colony from Schizosac-
charomyces pombe strain 428-4-1 was inoculated in 5 mL
of YEB medium and grown at 30 °C during 12 h until OD600
) 0.5. From this culture, 250 íL was transferred to 50 mL
of the same medium and grown overnight at the same
temperature. When the OD600 ) 0.8, cells were collected by
centrifugation and broken using small glass pearls. A cellular
pellet was resuspended in 500 íL of sterile water at 50 °C,
and the extract was separated from cellular debris by
centrifugation. Total DNA was purified using a total DNA
extraction kit (Qiagen GmbH, Germany). Total DNA solution
was measured at 260 nm in a GENESYS 10 spectropho-
tometer, reaching a concentration of 3.8 íg/íL. The solution
was also run on agarose gel (0.8%), and high integrity was
seen.
3.3. Primer Design. Forward (PAC5′) 5′-cccATGG-
GACGGTTTAAGAGGCATC-3′ and reverse (PAC3′) 5′-
gtggggttaacgggcaaacTTAG-3′ primers were designed based
on the previously reported pac1+ coding sequence from
Schizosaccharomyces pombe mutant snm1-1. The primer
sequences show the restriction sites Nco1 and Kpn1 intro-
duced at the 3′ and 5′ ends, i.e., the first ATG and the stop
TTA codon. The coding regions are shown in capital
letters.138
3.4. PCR Amplifications. Amplification of the pac1+ gene
from Schizosaccharomyces pombe was performed by stan-
dard PCR from its total DNA. The reaction mixture contain-
ing 10 ng of template, 1 mM of each dNTP, 1.5 mM MgCl2,
2 íM of each PAC5′ and PAC3′ primers, 1 buffer Taq
Pol (Gibco BRL), and 2.5 U Taq Pol (Gibco) was completed
to a total volume of 50 íL. The PCR was carried out using
a thermocycler (Perkin-Elmer 2400) programmed as fol-
lows: 5 min initial template denaturation at 94 °C, cycle
stepss1 min template denaturation at 94 °C, 2 min primer
annealing at 45 °C, 2 min primer extension at 72 °C for 30
cycles, plus a final extension step at 72 °C for 5 min.29,30,138
PCR reaction showed a band coinciding with the size of the
reported pac1+ ORF.138
3.5. Plasmid Construction and Sequencing. The PCR
amplification product was purified using a GEL Band Purifi-
cation kit (AmershamPharmaciaBiotech) and ligated to
pMOS-Blue T-vector (AmershamPharmaciaBiotech). The
ligation was transformed into electrocompetent E. coli DH5R
by electroporation in 0.2 mm cuvettes using a Gene Pulser
Machine (BioRad) (12.5 kV, 25 íF, 1000 ö). The transfor-
mation was plated onto LB medium supplemented with 40
íL of 20 íg/mL X-gal solution and 4 íL of isopropylthio-
â-D-galactoside from a 200 íg/mL IPTG solution per plate
and allowed to grow overnight at 37 °C. White coloniess
presumably carrying the recombinant pac1 gene inserted in
pMOS-Blue T-vector, named pRSPac1swere selected, and
plasmid DNA was extracted for analysis of the cloned frag-
ment by restriction enzymes. Sequencing of the cloned frag-
ment was performed using an ABI 3700 sequencer (Applied
Biosystems),139 and this showed a product of 1.111 Kb.
3.6. Purification of Recombinant Pac1. A single colony
of E. coli DH5R with pRSPac1 was grown overnight at 30
°C in 5 mL of LB medium supplemented with carbencillin
at 100 íg/mL. 250 íL of culture was then inoculated to 250
mL of the same medium supplemented with carbenicillin
(100 íg/mL) and grown under the same culture conditions
until OD600 ) 0.8; at this point 50 íL of 200 íg/mL IPTG
solution was added to the culture. Three hours after induction,
cells were harvested by centrifugation and washed with 15
mL of 50 mM tris-HCl (pH 8), 100 mM NaCl, and 1 mM
EDTA. Cells were collected by centrifugation and stored at
-70 °C overnight. Around 3 g of frozen cells was resus-
pended in 15 mL of lysis buffer (1% NP40, 0.5% sodium
deoxycholate, 0.1 M NaCl, 30 mM Tris-HCl (pH 8), 1 mM
EDTA), and 5 mM MgCl2 and DNase1 (10 íg/mL) were
added. The cell suspension was incubated on ice for 10 min.
Inclusion bodies were collected by washing four times with
lysis buffer and twice with 50 mM Tris-HCl 5 mM (pH 8),
1 mM DTT. Finally, the sample was dissolved in 5 mL of
loading buffer and boiled in a water bath for 10 min. The
total volume of extract was divided into five preparative
PAGE electrophoresis samples containing 1 mL of protein
extract, which were run in 12% gel. The component
corresponding to 45.5 kDa recombinant Pac1 protein was
visualized by staining with an aqueous solution of 0.05%
Coomassie brilliant blue R250. In each case the recombinant
protein was excised from polyacrylamide gel, recovered by
electroelution, combined, concentrated with Centricon-10
(Amicon) to 0.5 mL, and diluted to 1.5 mL with a storage
buffer to a final composition of 500 mM NaCl, 20 mM
sodium phosphate (ph 7.4), 67 mM imidazole, 1 mM DTT,
1 mM EDTA, and 30% glycerol. The recPac1 preparation
was stored at -20 °C.29,30,138
Figure 3. k-MCA procedure for control group design.
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3.7. Synthesis and Preparation of Complementary RNA
Strands. The enzymatic assay of recombinant Pac1 was
carried out according to the optimized conditions described
by Rotondo and Frendewey.29 In a previous experiment (data
not shown) we amplified by PCR a fragment corresponding
to the fourth intron of Schizosaccharomyces pombe â-tubu-
line from its total DNA and inserted the amplified fragment
into pBluescript II KS (-) for further in vitro transcription
purposes. The integrity of the amplified sequence and
transcriptional fusion was tested by sequencing. We repro-
duced exactly the described assay to compare the activity
of our recombinant enzyme with the results from other
reports. This construction was used as a template for the PCR
of fragments corresponding to transcriptional-fusion suitable
for the synthesis of both complementary strands of dsRNA
substrate for an in vitro transcription reaction. For this
purpose the following primers were synthesized: a) 5′- gctc-
ggaattaaccctcactaagVggaacGTAGGTTTTTTTGCTTTC-3′ (T3
promoter in lower case, 5′ end of the Schizosaccharomyces
pombe â-tubuline fourth intron in upper case) and b) 5′-ggt-
acctaatacgactcactatagVggagaCTACAGTCGTCAGTAC-3′ (T7
promoter in lower case, complement of the 3′ end of the
Schizosaccharomyces pombe â-tubuline fourth intron in
upper case).
The arrows indicate the transcription initiation site. The
PCR products were purified, and 50 ng of each was used to
synthesize both complementary strands of the dsRNA Pac1
substrate. The transcription reactions were prepared in a final
volume of 20 íL containing 40 mM Tris-HCl (pH 7.9), 6
mM MgCl2, 2 mM spermedine, 10 mM DTT, 0.5 mM of
each ribonucleoside (Amersham Pharmacia Biotech), 50 íCi
[R32 P] UTP (800 Ci/mmol), 20 U RNAsin (Promega), and
20 U T3 or T7 RNA polymerase (Amersham Pharmacia
Biotech). In the case of the transcription reaction driven by
the T3 promoter, the addition of 50 mM NaCl to the reaction
mixture was required. In all cases the reactions were prepared
on ice and were then incubated at 37 °C during 10 min. The
resulting transcripts were treated with DNAse I (Promega),
phenol extraction and precipitation with 2.5 V/V of absolute
ethanol were carried out, and the samples were stored
overnight at -70 °C. The complementary RNA strands were
collected by centrifugation at 16 000g during 10 min at 4
°C. Finally, the pellets were washed with 70% ethanol, dried,
resuspended in diethyl pyrocarbonate treated with distilled
water, and stored at -70 °C.
3.8. Preparation of dsRNA Substrate for Pac1 Enzy-
matic Assay. Equimolar quantities of both complementary
strands were mixed in diethyl pyrocarbonate and treated with
distilled water to give a final volume of 50 íL. The mixture
was heated during 10 min at 100 °C in a water bath. The
whole bath was then firmly closed and placed into thermal
box overnight to allow annealing of both complementary
strands into the dsRNA substrate. The unpaired ends and
RNA strands were removed by RNase A (Promega) treat-
ment. The dsRNA substrate was purified (PAGE-TBE 15%
gel) and stored in diethyl pyrocarbonate (DEPC) treated
distilled water at -70 °C. The substrate for the Pac1 assay
consisted of 101 bp dsRNA, identical to the substrate used
by Rotondo and Frendewey.29
3.9. Enzymatic Assay of Recombinant Pac1. The Pac1
assay was carried out using the following conditions: 30
mM Tris-HCl (pH7.6), 1 mM DTT, 5 mM of MgCl2, 10
nM of dsRNA substrate, and different quantities (0, 1, 10,
100 nM) of purified recombinant Pac1 enzyme. Enzymatic
reactions were completed on ice, started by the addition of
0.1 V of 50 mM MgCl2, incubated at 30 °C for 10 min, and
stopped by the addition of 500 íL of 5% ice-cooled TCA
followed by 15 min on ice. The aliquots were centrifuged at
16 000g during 5 min in a Spin-X filter unit (Costar). The
soluble fractions (filtrate) were quantified by liquid scintil-
lation counting. The counting data represent the amount of
acid-precipitable polynucleotide phosphorus (dsRNA) sub-
strate transformed into acid soluble cleavage products by
Pac1 enzyme. The procedure was repeated three times with
three repetitions per experiment.29,30,138
4. RESULTS AND DISCUSSION
4.1. MMM-QSAR Model To Predict Type III RNAses
without Alignment. Many different parameters can be used
to encode protein sequence information and further assign
or predict the function or physical properties of proteins and
their mutants.140,141 The present approach involves the
calculation of different sequence parameters based on MMs,
which can be applied to different kinds of molecular graphs131
including DNA, RNA, and proteins.93,142 MMs have been
applied successfully to genomics and proteomics and rep-
resent an important tool for analyzing biological sequence
data. In particular, MMs have been used for protein folding
recognition143 and the prediction of protein signal se-
quences.144,145 MMs have also been applied to predict alpha
turns146 and beta turns147 as well as other tight turns and their
types.148 Particularly, MMs have been further used to predict
the specificity of GalNAc-transferase149 and cleavage sites
in proteins by proteases,150-153 greatly stimulating the
development for drug design against AIDS and SARS.154-162
In this work we calculated MMMs (HPðk) of the stochastic
matrix that describe the distribution of the amino acids of
the protein sequence in the 2D-HP graph. This calculation
was carried out for two groups of protein sequences, one
made up of RNase III-like enzymes and the other formed
by heterogeneous proteins. This last group contains 133
members, and these were selected as follows:
Original data were submitted to k-MCA as described
previously.136 The k-MCA divided the data into four clusters
containing 439, 684, 592, and 469 members, respectively.
Selection was based on the distance from each member with
respect to the cluster center (Euclidean distance). We selected
the closer cases to the center in order to ensure the inclusion
of representative members of each cluster in the control
group. Depending on the cluster size, a proportional number
of proteins were set; 27 cases were taken from the first
cluster, 42 from the second, 36 from the third, and 28 from
the fourth to give a total of 133 members in the control group.
We always bore in mind the principle of discriminant analysis
in terms of balancing the size of the control group with
respect to the RNase III group. A simple MMM-QSAR was
then developed to classify a novel sequence as RNase III or
not. The best equation found for this purpose was
The statistical parameters for the above equation were
Wilk’s statistic (ì ) 0.18), Mahalanobis’s distance (D2 )
RNaseIII - score )
35.46  HPð0 - 33.36  HPð2 - 2.22 (3)
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16.36), and error level (p-level < 0.001).163 This discriminant
function misclassified only four cases out of 214 proteins
used in both the training and validation series, reaching a
high level of accuracy of 98.13%. More specifically, the
model classified correctly 77/81 (95.06%) of RNase III-like
enzymes and 100% of the control group. The respective
classification matrices for training and cross-validation are
depicted in Table 1. Analyzing the definition of MMMs in
above equations, it is important to highlight that the
combination of a positive contribution of HPð0 and a negative
contribution of HPð2 in eq 3 points to a HP folding rule for
the biological activity. The higher the number of HP-folded
nodes (evaluated by HPð0) and the lower the number of
middle-range self-return HP-folding walk (HPð2) the higher
will be the assigned activity score. Thus, highest scores for
classification of RNase III-class are proportionally related
not only to the content of hydrophobic residues in the protein
sequence but also to the middle-range patterns formed by
the backbone in the HP-lattice folding process. Otherwise,
the folding patterns at long-range (MMM3...) within the lattice
do not directly affect the final assigned biological activity
score.
A validation procedure was subsequently performed in
order to assess the model predictability. This validation was
carried out with an external series of 20 RNase III-like
proteins and a further 43 diverse proteins (see Table 1). The
present model showed an average predictability of 100% for
each group, which is remarkable in comparison to results
obtained by other researchers on using the LDA method in
QSAR studies.164-167 These results are also consistent with
many others we have recently reviewed in-depth and
published in the form of a review article on the uses of
different networklike indices in small-sized, nucleic acids,
and proteins QSAR.167 In addition, we carried out a clas-
sification analysis with all of the proteins included. These
results provide further evidence of the robustness of the
Figure 4. Receiver operating characteristic curve (ROC-curve) for
training (dark line), validation (dot line), and random classifier (tight
line) with areas under the curve of 0.99, 0.97, and 0.5, respectively.
Figure 5. 2D-HP map superposition of RNases from prokaryotes
(dark gray), eukaryotes (in light gray), and rPac1 DQ647826 from
Schizosaccharomyces pombe strain 428-4-1 (in black).
Figure 6. BLASTp analysis for rPac1 protein sequence DQ647826.
Note that the scale of scoring is progressive in darkness. Sequence
names are not depicted.
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results obtained. The receiver operating characteristic (ROC)
curve was also constructed for the training and validation
series. Notably, the curve presented a pronounced curvature
(convexity) with respect to the y ) x line for both series
(see Figure 4). This result confirms that the present model
is a significant classifier, having areas of 0.99 (training) and
0.97 (validation)si.e. markedly higher than 0.5, which is
the value for a random classifier.168
4.2. Isolation, Prediction, and Assay of a Novel Pac1
from Schizosaccharomyces pombe Strain 428-4-1. 4.2.1.
Isolation. In this work we isolated, cloned, and expressed a
new Pac1 DNA sequence from Schizosaccharomyces pombe
strain 428-4-1, and its nucleotide and amino acid sequence
was recorded on the GenBank database with accession
number DQ647826. The theoretical prediction of its trans-
lated ORF as an RNase III-like enzyme was performed by
the present alignment-independent approach instead of
traditional alignment methods. The theoretical prediction of
rPac1 as a double-stranded RNase was confirmed experi-
mentally by in vitro assays.
4.2.2. Prediction. Our Pac1 protein sequence was analyzed
using the MMM-QSAR methodology with the aim of
recognizing the rPac1 gene product as a eukaryotic RNase
III homologue. The sequence was represented in a Cartesian
2D system and calculated including the whole data set. This
particular case was included in the validation subset in order
to make a prediction. The MMM-QSAR model although very
simple (two variables) allowed the correct classification of
the rPac1 product as an RNase III-like enzyme with the
maximum probability (p ) 1). In order to make a graphical
Figure 7. Clustal X sequence alignment involving RNase III-like enzymes. Each sequence is represented by its accession to the GenBank
Database Protein. Sequences used in the alignment were represented previously in the Cartesian 2D system (Figure 3). We use sequences
from bacteria and rPac1 from S. pombe. [ZP_01171567] Bacillus sp. NRRL B 14911, [AAT60616] Bacillus thuringiensis, [BAD75477]
Geobacillus kaustophilus HTA426, [ZP_01275092] Lactobacillus reuteri, [Q82ZG1] Enterococcus faecalis, [NP_687738] Streptococcus
agalactiae 2603VR, [AAA79829] E. coli, [YP_040620] Staphylococcus aureus MRSA252, [DQ647826] S. pombe strain 428-4-1.
Figure 8. Clustal X sequence alignment involving RNase III-like enzymes. Each sequence is represented by its accession to the GenBank
Database Protein. Sequences used in the alignment were represented previously in the Cartesian 2D system (Figure 3). We use sequences
from some representative eukaryotes and rPac1 from S. pombe. [XP_717277] Candida albicans SC5314, [XP_457193] Debaryomyces
hansenii CBS767, [NP_013966] Saccharomyces cereVisiae, [XP_449570] Candida glabrata CBS138, [XP_456185] KluyVeromyces lactis,
[DQ647826] S. pombe strain 428-4-1, [EAL91634] Aspergillus fumigatus Af293, [XP_790161] Strongylocentrotus purpuratus.
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comparison between our methodology and alignment meth-
ods like BLASTp,169-172 several representative RNase III
protein sequences from prokaryotes and eukaryotes were
selected together with rPac1 for representation in a 2D-
mapping system (see Figure 5).
The 2D-HP map protein representation introduced here
revealed a significant separation for the groups consisting
of dsRNases from prokaryotes (in dark gray) and eukaryotes
(in light gray). The rPac1 protein (in black) is placed between
the two groups, acting as a sort of link between the RNase
III families. This representation possibly supports evolution-
ary relationships between double-stranded RNase protein
sequences. Since the Cartesian 2D protein representation is
mainly based on amino acid composition, we can highlight
a major region from rPac1 matching eukaryote sequences
(in light gray) and another small region that lies within the
prokaryote region (in dark gray). There is also a nonmatching
region specific for rPac1 in Schizosaccharomyces pombe that
does not exist in other eukaryotes. However, matching
regions in the graph made a significant contribution to
calculation of the spectral moments, thus allowing successful
recognition of rPac1 as RNase III. These results coincide
with the use of different variants of 2D-HP folding maps
for proteins.173-175
We also performed an alignment between the previously
selected sequences and our rPac1 product using the Clustal
W program, version 1.81 (see Figures 7 and 8). Alignment
results coincide with those obtained in previous studies
reported by other authors. The rPac1 showed low amino acid
identity percentages in comparison to dsRNase sequences
from other eukaryote organisms, even for those belonging
to yeast-related species. Short and less frequent regions match
along the protein sequences, especially toward the N-terminal
region (see Figure 8). The comparison with prokaryote
sequences showed a matching region toward the protein’s
C-terminal part, from the 170 up to the 260 amino acid
position. This region corresponds with the RNase III C-
terminal domain (RIBOc), which is conserved in eukaryotic,
bacterial, and archeal RNase III and is associated with the
catalytic activity. There is a significant N-terminal region
in the Pac1 product that does not appear in the RNase III
prokaryote familysa finding consistent with other reports
(see Figure 7).29 A BLAST169-172 analysis was carried out
on the translated rPac1 DNA sequence (see Figure 5). This
method recognized successfully our query sequence as a Pac1
ribonuclease, reaching up to 98% of amino acid identity with
others already recorded from Schizosaccharomyces pombe
strains. Although this analysis showed lower scores (close
to 80%) in comparison to other typical dsRNases, the
approach still enabled protein query recognition as RNase
III. With the aim of comparing different methods, it is
possible to set an equivalence for the score value (80%) from
BLAST with our predicted probability, p ) 1, for rPac1 to
act as an RNase III-like enzyme. BLAST also revealed low
amino acid identity (<40%) toward the C-terminal portion
despite this representing the highest conserved region in the
four existing RNase III subclasses.169-172
On the other hand, as mentioned previously, each sequence
included in the study was submitted to InterProt. All cases
(100%) from the RNAse III group matched significantly with
RNase III domains (IPR000999), allowing the total recogni-
tion as dsRNases (see Table ISM). In the case of the control
group, six cases did not have InterProt identification, and
three of them did not have any hits reported (95, 50% of
predictability) (see Table IISM). These results confirm that
our model replaces neither classical methods for protein
function annotation like BLAST169-172 and InterProt122,176 nor
new alignment techniques based on partial order, secondary
structure, or gene ontology177-180 but becomes an interesting
alternative toolsespecially due to its alignment-independence
and simplicity. It is also important to highlight that our
methodology can be considered as a good classifier, despite
its simplicity, as it gives rise to a linear equation with two
variables at most.181 Thus, once the whole database has been
screened and proteins having the desired function are
recognized, it would be worthwhile to assess results obtained
using our approach using other methodologies.
In order to compare the MMM-QSAR approach reported
here with other methodologies based on MM, training and
negative (non-RNAses sequences) sets were scored with a
classic HMMs.176,182-190 Classification driven by an HMM
built on the original training set resulted in an accuracy of
98.75% for the positive sequences (training set) and 96.24%
for the negative sequences (see Table 2). Our query sequence
DQ647826 was also successfully predicted with the maxi-
mum score by the HMM.
4.2.3. Experimental EVidence for RNase III ActiVity.
Recombinant Pac1 protein from Schizosaccharomyces pombe
strain 428-4-1 was purified in order to measure its double-
stranded RNase activity in vitro. The corresponding product
size (45.5 kDa) coincided with the reported size for the native
protein (see Figure 9). Double-stranded activity was mea-
sured in vitro by following the protocol described above.
Figure 9. Electrophoresis of rPac1 protein. 45 kDa rPac1 was
purified and loaded in 12.5% PAGE-SDS and stained with
Coomassie brilliant: (a) band corresponding to rPac1 purified and
(b) molecular weight markers66.2 kDa, 45.7 kDa, 31 kDa, 21.5
kDa, and 14.4 kDa (unstained SDS-PAGE standards broad range,
BioRad).
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The unit definition for all RNase III types is the amount of
enzyme able to solubilize 1 nmol of acid-precipitable
radioactivity per hour.17 Pac1 activity showed values com-
parable to other results (5  105 U/mg) obtained for a
recombinant Pac1 product from Schizosaccharomyces
pombe by Rotondo and Frendewey.29 Results derived from
the enzymatic activity assay are shown in Table 3 for each
experiment; the mean value was 6.96  105 U/mg.
The kinetic enzymatic reaction of rPac1 by monitoring
dsRNA integrity (lanes 2-5) is illustrated in Figure 10.
These last experiments for the DQ647826 sequence were
not carried out to validate the MMM-QSAR model but to
show how to use it for predicting RNase III-like protein
function annotation. We recall that the validation of the
MMM-QSAR model was assessed with the external predic-
tion series as recommended for any QSAR studies (see
previous sections).191
5. CONCLUSIONS
The work described here introduces a new approach to
predict RNase type III function from protein sequences
irrespective of sequence alignment using the MMMs associ-
ated with a 2D sequence representation as the input for an
LDA classifier. This MMM-QSAR classifier successfully
discriminates between RNase-like sequences and a control
group. The Pac1 gene product was chosen as a representative
example of a sequence with low amino acid identity
compared to other enzymes with similar activity. The present
methodology achieves high classification scores similar to
bioinformatics tools based on sequence alignment (BLASTp)
and comparable results to other predicting protein function
annotation methods like InterProt and HMMs. The predic-
tions made by the present model coincide with outcomes
from experimental isolation, expression, and enzymatic
Figure 10. Autoradiography of rPac1 enzymatic assay. To visualize the cleavage activity of the dsRNA substrate generated by T3/T7 “in
vitro” transcription, aliquots of enzymatic assay were taken at 2, 5, and 10 min, loaded in 12.5% PAGE/7 M urea followed by autoradiography.
Lane 1 is pBR322 digested by Msp1. Lane 2 is the intact dsRNA substrate. Lanes 3-5 are the results of rPac1 enzymatic activity at 2, 5,
and 10 min of reaction at 30 °C. Lanes 6 and 7 are the T3 and T7 ssRNA obtained by “in vitro” transcription too which are not degradated
by RNAse activity of Pac1.
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activity measurement of a novel pac1+ gene sequence
DQ647826 isolated from a new isolate Schizosaccharomyces
pombe strain 428-4-1. The work promotes the use of the
experience accumulated in small-molecules QSAR with
spectral moments192 and other kinds of indices in new types
of proteins QSAR studies, now a focus of interest for many
researchers worldwide.193-197
List of Abbreviations. HP - hydrophobicity and polarity;
RNases - ribonucleases; QSAR - quantitative structure-
activity relationships; dsRNase - double-strand-specific
ribonuclease; snRNAs - small nucleolar RNA; LDA -
linear discriminant analysis; ORF - open reading frame;
MM - Markov model; HMM - hidden Markov model;
ROC curve - receiver operating characteristic curve.
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